While these rare cells only occupy very minor proportions (e.g. 0.09%), they are key biomarkers for several brain diseases including multiple system atrophy [30] (Sncg), glioblastoma [31] (Serpinf1) and brain edema [32] (Astro). This evidence concerns the gene SERPINF1 and multiple system atrophy.